Speakers

Distinguished Co-Chairs:

Stephen C. Cipolla
Counsel
Merck & Co., Inc. (North Wales, PA)

Jonathan Wasserman
Vice President & Associate General Counsel
Bristol-Myers Squibb (Plainsboro, NJ)

Hear from key government officials directly involved in pharmaceutical antitrust enforcement:

Federal Trade Commission:

Commissioner J. Thomas Rosch

Michael B. Kades
Attorney Advisor to Chairman Jon Leibowitz

Tara Isa Koslov
Deputy Director, office of Policy Planning

Bureau of Competition:

Richard Feinstein
Director

Michael Moiseyev
Assistant Director, Mergers 1 Division

Christine White
Attorney, Healthcare Division

Kenneth L. Glazer
Partner,K&L Gates (Washington, DC)
Former Deputy Director, Bureau of Competition, FTC

European Commission, DG Competition,Pharmaceuticals Task Force:

Satish Sule
 

Lars Kjølbye
Partner, Covington & Burling LLP (Brussels, Belgium)

Former head of unit for antitrust in the energy and environment sectors in DG Competition

Brazil:

José Antonio B. M. Ziebarth
Advisor to Brazilian Competition Tribunal